Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

The Use of Antibiotics in Hospice and Palliative Care Settings

  • Shekhar, Aditya C. (Center for Bioethics, Harvard Medical School)
  • Received : 2021.12.05
  • Accepted : 2022.02.09
  • Published : 2022.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Antibiotics are commonly prescribed medications in the hospice and palliative care setting, as well as in many other healthcare settings. The overuse or negligent use of antibiotics is associated with the harmful consequence of fostering the development of antibiotic-resistant pathogens. Thus, there is an urgent need to critically examine and audit antibiotic use in all aspects of healthcare. In the status quo, there is a lack of consistent standards and guidelines surrounding the use of antibiotics in hospice and palliative care settings, leading to significant variations in how antibiotics are prescribed and administered in end-of-life care. It is apparent that greater thought needs to go into antibiotic decisions for patients receiving hospice or palliative care, especially considering the harmful consequences of the overprescription of antibiotics. The literature suggests that many clinicians prescribe antibiotics inappropriately for patients who would not benefit from their use or prescribe them without adequate documentation. Clinicians should be deliberate about when they prescribe antibiotics and adhere to the appropriate documentation standards and procedures within their institution or community. Future research should seek to generate generalizable knowledge about which patients will benefit most from antibiotic therapy during end-of-life care.

Keywords

References

  1. Dosani S. Penicillin man: Alexander Fleming and the antibiotic revolution. BMJ 2005;330(7481):50.
  2. Capote AP, Suarez ALT, Gutierrez MMM, Almarales BRQ. Alexander Fleming and the antibiotic revolution. INMEDSUR 2018;1:72-7.
  3. Hamad B. The antibiotics market. Nat Rev Drug Discov 2010;9:675-6. https://doi.org/10.1038/nrd3267
  4. Rosenberg JH, Albrecht JS, Fromme EK, Noble BN, McGregor JC, Comer AC, et al. Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review. J Palliat Med 2013;16:1568-74. https://doi.org/10.1089/jpm.2013.0276
  5. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, et al. Antimicrobial resistance. Is a major threat to public health. BMJ 1998;609-10.
  6. Hulscher ME, Grol RP, Van Der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010;10:167-75. https://doi.org/10.1016/S1473-3099(10)70027-X
  7. Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med 2013;368:299-302. https://doi.org/10.1056/NEJMp1215093
  8. CDC: Antibiotic/Antimicrobial Resistance (AR/AMR) [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2020 [cited 2020 Jul 20]. Available from: https://www.cdc.gov/drugresistance.
  9. Lee GC, Reveles KR, Attridge RT, Lawson KA, Mansi IA, Lewis JS 2nd, et al. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC Med 2014;12:96. https://doi.org/10.1186/1741-7015-12-96
  10. Ford PJ, Fraser TG, Davis MP, Kodish E. Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients. Bioethics 2005;19:379-92. https://doi.org/10.1111/j.1467-8519.2005.00450.x
  11. Clark MD, Halford Z, Herndon C, Middendorf E. Evaluation of antibiotic initiation tools in end-of-life care. Am J Hosp Palliat Care 2022;39:274-81. https://doi.org/10.1177/10499091211027806
  12. Oneschuk D, Fainsinger R, Demoissac D. Antibiotic use in the last week of life in three different palliative care settings. J Palliat Care 2002;18:25-8. https://doi.org/10.1177/082585970201800105
  13. Albrecht JS, McGregor JC, Fromme EK, Bearden DT, Furuno JP. A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage 2013;46:483-90. https://doi.org/10.1016/j.jpainsymman.2012.09.010
  14. Furuno JP, Noble BN, Horne KN, McGregor JC, Elman MR, Bearden DT, et al. Frequency of outpatient antibiotic prescription on discharge to hospice care. Antimicrob Agents Chemother 2014;58:5473-7. https://doi.org/10.1128/AAC.02873-14
  15. Servid SA, Noble BN, Fromme EK, Furuno JP. Clinical intentions of antibiotics prescribed upon discharge to hospice care. J Am Geriatr Soc 2018;66:565-9. https://doi.org/10.1111/jgs.15246
  16. Fong K, Oravec M, Radwany S. Antibiotic use in hospice patients (S745). J Pain Symptom Manage 2017;53:434-5. https://doi.org/10.1016/j.jpainsymman.2016.12.255
  17. Pereira J, Watanabe S, Wolch G. A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit. J Pain Symptom Manage 1998;16:374-81. https://doi.org/10.1016/S0885-3924(98)00093-1
  18. Chochinov HM. Dignity-conserving care-a new model for palliative care: helping the patient feel valued. JAMA 2002;287:2253-60. https://doi.org/10.1001/jama.287.17.2253
  19. Reinbolt RE, Shenk AM, White PH, Navari RM. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005;30:175-82. https://doi.org/10.1016/j.jpainsymman.2005.03.006
  20. White PH, Kuhlenschmidt HL, Vancura BG, Navari RM. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2003;25:438-43. https://doi.org/10.1016/S0885-3924(03)00040-X
  21. Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 2000;20:326-34. https://doi.org/10.1016/S0885-3924(00)00189-5
  22. Helde-Frankling M, Bergqvist J, Bergman P, Bjorkhem-Bergman L. Antibiotic treatment in end-of-life cancer patients-a retrospective observational study at a palliative care center in Sweden. Cancers (Basel) 2016;8:84. https://doi.org/10.3390/cancers8090084
  23. Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes-what's missing? J Antimicrob Chemother 2010;65:2275-7. https://doi.org/10.1093/jac/dkq357
  24. Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep 2016;65:1-12.
  25. Mitchell SL, D'Agata EM, Hanson LC, Loizeau AJ, Habtemariam DA, Tsai T, et al. The trial to reduce antimicrobial use in nursing home residents with Alzheimer disease and other dementias (TRAIN-AD): a cluster randomized clinical trial. JAMA Intern Med 2021;181:1174-82. https://doi.org/10.1001/jamainternmed.2021.3098
  26. Macedo F, Nunes C, Ladeira K, Pinho F, Saraiva N, Bonito N, et al. Antimicrobial therapy in palliative care: an overview. Support Care Cancer 2018;26:1361-7. https://doi.org/10.1007/s00520-018-4090-8
  27. Stiel S, Krumm N, Pestinger M, Lindena G, Nauck F, Ostgathe C, et al. Antibiotics in palliative medicine-results from a prospective epidemiological investigation from the HOPE survey. Support Care Cancer 2012;20:325-33. https://doi.org/10.1007/s00520-011-1084-1
  28. Donald L, Lindsay F. Antibiotic stewardship in palliative care - development of antibiotic prescribing guidelines for a hospice inpatient unit. BMJ Support Palliat Care 2014;4(Suppl 1):A62-3. https://doi.org/10.1136/bmjspcare-2014-000654.16
  29. Matthews A, Kirupanadan A, O'Dea R, Duttagupta T, Ferguson J, Kayani S. Antibiotic stewardship in a hospice environment: an audit of start smart then focus. BMJ Support Palliat Care 2018;8(Suppl 2):A52.
  30. Juthani-Mehta M, Malani PN, Mitchell SL. Antimicrobials at the end of life: an opportunity to improve palliative care and infection management. JAMA 2015;314:2017-8. https://doi.org/10.1001/jama.2015.13080